effect of angiogenesis inhibitor bevacizumab on survival in patients with cancer a meta-analysis of the published literature血管生成抑制剂贝伐单抗对患者生存的影响癌症的荟萃分析文献发表.pdfVIP

  • 4
  • 0
  • 约6.97万字
  • 约 8页
  • 2017-09-13 发布于上海
  • 举报

effect of angiogenesis inhibitor bevacizumab on survival in patients with cancer a meta-analysis of the published literature血管生成抑制剂贝伐单抗对患者生存的影响癌症的荟萃分析文献发表.pdf

effect of angiogenesis inhibitor bevacizumab on survival in patients with cancer a meta-analysis of the published literature血管生成抑制剂贝伐单抗对患者生存的影响癌症的荟萃分析文献发表

Effect of Angiogenesis Inhibitor Bevacizumab on Survival in Patients with Cancer: A Meta-Analysis of the Published Literature Yuan Su., Wei-Bing Yang., Shi Li, Zhi-Jian Ye, Huan-Zhong Shi*, Qiong Zhou* Key Laboratory of Pulmonary Diseases of Health Ministry, Department of Respiratory Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China Abstract Bevacizumab is a recombinant humanized monoclonal antibody against vascular endothelial growth factor which has been used in conjunction with other anti-cancer agents in th

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档